Abstract:BACKGROUND: Pompe disease is a rare, progressive, and life-threatening autosomal recessive disorder. In its late-onset form, the disease is primarily characterised by mild progressive proximal limb and respiratory muscle weakness. Mutations in the acid alpha-glucosidase (<i>GAA</i>) gene cause lysosomal enzyme GAA to be significantly reduced or missing altogether, for which supplementation can be given through enzyme replacement therapy.METHODS: Fourteen patients diagnosed with late-onset Pompe disease (LOPD) in the First Affiliated Hospital of Nanjing Medical University from 2017 to 2021 were enrolled. GAA activity was measured based on enzymatic activity in dried blood spots, and next-generation sequencing was used to detect mutations in the <i>GAA</i> gene. The impacts of novel missense variants were determined by five different prediction algorithms. The structural figures of novel variants and their wide types were processed with PyMOL.RESULTS: The study included 14 patients with LOPD (male-to-female ratio, 1:1) from eastern China. The median age at symptom onset and diagnosis was 15.0 years (7-36 years) and 21.5 years (8-47 years), respectively. The median diagnostic delay from onset was 3.0 years (0-22 years). Proximal muscle weakness was the first prominent symptom in 8 patients, while the other 6 patients experienced respiratory failure, chest congestion and asthma, and scoliosis. The most frequent mutation of the GAA gene was c.2238G>C (p.W746C), which was observed at an allele frequency of 14.3% (4/28) and in 28.6% of patients (4/14). Four novel variants potentially related to the pathogenicity of LOPD were found: c.1299G>C (p.Q433H), c.1409A>G (p.N470S), c.2242delG (p.E748Rfs*16), and c.2832delA (p.E945Sfs*78).CONCLUSIONS: The c.2238G>C (p.W746C) mutation was the most common mutation in 14 patients with LOPD from eastern China. This study has identified four novel variants in patients with LOPD. Predicting the pathogenicity of these novel variants may increase the understanding of the genetic mutation spectrum in LOPD. Our findings may also improve recognition of the characteristics of Chinese patients with LOPD.

Analysis of Phenotype, Enzyme Activity and Genotype of Chinese Patients with POMT1 Mutation.

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

Clinical Exome Sequencing Identifies Novel Compound Heterozygous Mutations of the POMT2 Gene in Patients with Limb‐girdle Muscular Dystrophy

Clinical and genetic analysis of a Chinese family with Walker-Warburg syndrome

[Clinical and Mutation Analysis of a Chinese Family with Muscle Eye Brain Disease].

Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China

[Analysis of GFM1 Gene Mutations in a Family with Combined Oxidative Phosphorylation Deficiency 1].

Clinical and Molecular Characterization of Infantile-Onset Pompe Disease in Mainland Chinese Patients: Identification of Two Common Mutations.

Genetic Variations and Clinical Spectrum of Dystroglycanopathy in a Large Cohort of Chinese Patients.

Mutation Analysis and Prenatal Diagnosis of EXT1 Gene Mutations in Chinese Patients with Multiple Osteochondromas.

Novel Copy Number Variation of POMGNT1 Associated with Muscle-Eye-brain Disease Detected by Next-Generation Sequencing

Indentification of novel MSTO1 compound heterozygous mutations in a Chinese family with recessive cerebellar atrophy and ataxia

Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family—The Role of Next Generation Sequencing in Neuromuscular Disorders

Molecular Interaction Between Fukutin and Pomgnt1 in the Glycosylation Pathway of Alpha-Dystroglycan

Clinical and Molecular Genetic Characterization of Two Patients with Mutations in the Phosphoglucomutase 1 (PGM1) Gene

Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations.

Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro

Clinical and genetic analysis of combined oxidative phosphorylation defificiency-10 caused by MTO1 mutation